Revenio Group Corporation | Stock Exchange Release | August 05, 2026 at 14:00:00 EEST
Revenio Group Corporation’s Board of Directors has approved the company's updated Disclosure Policy, which describes the key principles and practices that the company follows when communicating with the capital markets and other stakeholders.
The updated policy does not include major changes to the principles according to which Revenio Group operates. The policy has been updated primarily to reflect the amendments to the EU Market Abuse Regulation (EU) No 596/2014 (MAR).
The updated Disclosure Policy comes into effect immediately. The policy is attached to this release and is also available on the company’s website.
For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Main media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.
In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.